Ferrocin - instructions for use, dose, side effects, contraindications

Active substancePotassium-iron hexacyanoferratePotassium-iron hexacyanoferrate

Similar drugsTo uncover

pills inwards

Dosage form: & nbsppills

Composition:Composition per one tablet
Active substance:
Potassium-iron hexacyanoferrate - 500 mg
Excipients: kaolin - 46.0 mg; povidone - 18.0 mg; crospovidone - 30.0 mg; silicon dioxide colloidal - 3.0 mg; talc -3.0 mg

Description:Tablets are dark blue with light patches.

Pharmacotherapeutic group:Complexing agent

ATX: & nbsp

V.03.A.B Antidotes

Pharmacodynamics:Complexing compound. Strongly binds radioactive isotopes of cesium, rubidium and thallium, preventing their absorption from the intestine, which allows them to accelerate their excretion from the body.

Pharmacokinetics:Ferrozin® is not absorbed into the intestine and is completely eliminated from the body.

Indications:Intoxication with cesium, rubidium and thallium (including products of uranium fission), prevention of accumulation of radioisotopes in the body upon admission to the gastrointestinal tract with food.

Contraindications:

Hypersensitivity to any of the components of the drug.

If you have one of the listed diseases (conditions), before taking the drug always consult a doctor.

Pregnancy and lactation:

Data on the use of the drug Ferrozin® in pregnancy and during breastfeeding are absent.

Dosing and Administration:

Inside.Adults and children over 14 years - 2 tablets 3 times a day, taken daily, treatment course - up to 30 days (under the control of excretion of radionuclides); children older than 3 years, 1 tablet 3 times a day, for 5-10 days.

Side effects:

Possible side effects when using a medicinal product

From the digestive system: constipation, diarrhea;

Other: allergic reactions.

If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, report on this the doctor.

Overdose:No cases of an overdose of Ferrozin® were observed.

Interaction:

Reduces the effect of drugs containing alkaline metals, a simultaneous appointment with diuretics can lead to hypokalemia.

In the event that you take other medicines, before taking the drug always consult a doctor.

Effect on the ability to drive transp. cf. and fur:

The intake of the drug does not affect the ability to drive vehicles, mechanisms.

Form release / dosage:

Tablets 500 mg.

Packaging:

For 500 tablets in cans (bottles) of dark glass with screwed plastic caps or inplastic cans (bottles). On the jar, bottle or bottle stick a label of paper label.

For 1, 2 or 10 tablets in a contour mesh box made of polyvinyl chloride film and aluminum foil.

Contoured cell packs without a secondary (consumer) package for 1, 2 or 10 tablets are designed for special purposes.

1 circuit cell pack for 1, 2 or 10 tablets together with instructions for use in a pack of cardboard.

Storage conditions:

In a dry, protected from light place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

4 years.

The drug should not be used after the expiry date indicated on the package.

Terms of leave from pharmacies:For hospitals

Registration number:LSR-010485/08

Date of registration:24.12.2008

The owner of the registration certificate:FARMZASCHITA NPC, FSUE FARMZASCHITA NPC, FSUE Russia

Manufacturer: & nbsp

FARMZASCHITA NPC, FSUE Russia

Information update date: & nbsp21.11.2014

Illustrated instructions

Instructions

Ferrocyn® (Ferrocin®)